Trials / Sponsors / Nordic MDS Group
Nordic MDS Group
Network · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT MDS, SCT, MRD | — | 2016-08-01 |
| Unknown | The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leuk Myelodysplastic Syndrome, Acute Myelogenous Leukemia | Phase 2 | 2012-03-01 |
| Completed | Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) Myelodysplastic Syndrome, Thrombocytopenia | Phase 1 | 2011-10-01 |
| Completed | Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Ch Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia | Phase 2 | 2010-01-01 |
| Completed | Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5 MDS, AML | Phase 2 | 2007-10-01 |